Mutations in genes such as TSC1, TSC2, and MTOR itself, which lead to hyperactivation of the mTOR pathway, are central to the pathogenesis of diseases like tuberous sclerosis complex (TSC) and certain forms of cancer. Here, TSC2 is linked to tuberous sclerosis.